A detailed history of Israel Englander (Millennium Management LLC) transactions in Dexcom Inc stock. As of the latest transaction made, Millennium Management LLC holds 390,800 shares of DXCM stock, worth $29.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
390,800
Previous 36,300 976.58%
Holding current value
$29.4 Million
Previous $4.12 Million 536.48%
% of portfolio
0.01%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $17.7 Million - $32.2 Million
277,152 Added 429.75%
341,643 $22.9 Million
Q2 2024

Aug 14, 2024

SELL
$110.31 - $140.45 $65.1 Million - $82.9 Million
-590,105 Reduced 90.15%
64,491 $7.31 Million
Q1 2024

May 15, 2024

SELL
$114.22 - $140.1 $42.6 Million - $52.2 Million
-372,563 Reduced 36.27%
654,596 $90.8 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $66.2 Million - $109 Million
-876,306 Reduced 46.04%
1,027,159 $127 Million
Q2 2023

Aug 14, 2023

SELL
$112.47 - $130.98 $86.8 Million - $101 Million
-771,329 Reduced 28.84%
1,903,465 $245 Million
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $126 Million - $149 Million
-1,215,855 Reduced 31.25%
2,674,794 $311 Million
Q4 2022

Feb 14, 2023

BUY
$84.98 - $122.67 $226 Million - $326 Million
2,658,077 Added 215.65%
3,890,649 $441 Million
Q3 2022

Nov 14, 2022

BUY
$76.35 - $94.18 $20.1 Million - $24.8 Million
263,739 Added 27.22%
1,232,572 $99.3 Million
Q2 2022

Aug 15, 2022

BUY
$67.99 - $132.89 $50.5 Million - $98.7 Million
742,391 Added 327.85%
968,833 $72.2 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $4.95 Million - $6.85 Million
-52,606 Reduced 18.85%
226,442 $116 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $34.3 Million - $42.9 Million
263,737 Added 1722.53%
279,048 $150 Million
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $1.28 Million - $1.72 Million
-12,019 Reduced 43.98%
15,311 $8.37 Million
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $1.02 Million - $1.26 Million
12,051 Added 78.87%
27,330 $9.82 Million
Q4 2020

Feb 16, 2021

SELL
$78.0 - $104.5 $7.51 Million - $10.1 Million
-96,294 Reduced 86.31%
15,279 $5.65 Million
Q3 2020

Nov 16, 2020

SELL
$95.51 - $112.95 $8.22 Million - $9.72 Million
-86,078 Reduced 43.55%
111,573 $46 Million
Q2 2020

Aug 14, 2020

BUY
$62.68 - $105.34 $6.24 Million - $10.5 Million
99,509 Added 101.39%
197,651 $80.1 Million
Q1 2020

May 14, 2020

SELL
$47.79 - $75.63 $11.8 Million - $18.6 Million
-246,385 Reduced 71.51%
98,142 $26.4 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $10.6 Million - $16.6 Million
289,198 Added 522.69%
344,527 $75.4 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $14.6 Million - $18 Million
-409,938 Reduced 88.11%
55,329 $8.26 Million
Q2 2019

Aug 15, 2019

BUY
$27.84 - $38.92 $12.5 Million - $17.5 Million
449,520 Added 2854.64%
465,267 $69.7 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $18.1 Million - $25.3 Million
-649,379 Reduced 97.63%
15,747 $902,000
Q1 2019

May 14, 2019

SELL
$28.07 - $38.18 $414,257 - $563,460
-14,758 Reduced 2.17%
665,126 $79.2 Million
Q4 2018

Feb 14, 2019

SELL
$26.99 - $37.37 $17.4 Million - $24.1 Million
-644,136 Reduced 48.65%
679,884 $81.5 Million
Q3 2018

Nov 14, 2018

SELL
$23.35 - $36.72 $7.07 Million - $11.1 Million
-302,897 Reduced 18.62%
1,324,020 $189 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $12.2 Million - $17.6 Million
697,438 Added 75.04%
1,626,917 $155 Million
Q1 2018

May 15, 2018

BUY
$13.06 - $18.54 $6.84 Million - $9.7 Million
523,438 Added 128.91%
929,479 $68.9 Million
Q4 2017

Feb 14, 2018

BUY
$11.12 - $15.38 $4.52 Million - $6.24 Million
406,041
406,041 $23.3 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.